“…Four hours after exposure to aspirin in rats, we found the number of cells expressing RegI increases specifically in areas close to injury sites, in keeping with the findings of others (Asahara et al, 1996;Kawanami et al, 1997). Once adaptation is established, the number of RegIexpressing cells, and also the level of expression, is increased not only in areas that are injured but also throughout the mucosa in areas that appear macroscopically normal but are likely healing from earlier injury.…”
Section: Discussionsupporting
confidence: 90%
“…It has been clearly demonstrated that RegI is expressed only in endocrine cells, mostly enterochromaffin-like (ECL) cells, in normal and injured rat stomach (Asahara et al, 1996). Four hours after exposure to aspirin in rats, we found the number of cells expressing RegI increases specifically in areas close to injury sites, in keeping with the findings of others (Asahara et al, 1996;Kawanami et al, 1997).…”
Section: Discussionsupporting
confidence: 88%
“…RegI expression has been shown to increase up to 10-fold after a single high dose of indomethacin or after acute water immersion restraint stress (Asahara et al, 1996;Kawanami et al, 1997). In contrast, RegI was not significantly increased in the mucosa after the first aspirin dose in our experiments, although focal increases in expression at sites of injury were observed.…”
Section: Alderman Et Alcontrasting
confidence: 74%
“…RegI was first isolated in 1988 (Terazono et al, 1988) and, although much of the research to date has been concentrated on its role in the pancreas, it has also been shown to be expressed in normal stomach (Watanabe et al, 1990) and to increase after acute gastric mucosal injury (Asahara et al, 1996;Kawanami et al, 1997). In keeping with its mitogenic role in regenerating pancreatic islets, it has been suggested that RegI facilitates normal proliferation in the gastric epithelium and may also augment the proliferation of gastric epithelial cells after injury.…”
SUMMARY:The phenomenon of reduced gastric mucosal injury despite repeated doses of a damaging agent is termed adaptation. Adaptation to nonsteroidal anti-inflammatory drug-induced injury has been clearly demonstrated in both humans and experimental animals; however, the precise mechanisms remain unclear. We hypothesized that mediators of adaptation might be the regenerating protein (RegI) and the trefoil peptides TFF1 and TFF2, because these proteins play pivotal roles in gastric mucosal protection and repair. The gene expression and the protein levels of these proteins were measured and compared in normal, aspirin-injured, and aspirin-adapted rat stomachs. TFF gene and protein expression levels were similar in all three groups, whereas RegI gene expression and protein levels in adapted stomach were increased. A time course analysis of RegI expression during the onset and offset of adaptation showed that mucosal RegI increased during the development of adaptation, was maintained during subsequent aspirin dosing, and returned to baseline levels once dosing had ceased and adaptation was lost-indicative of a causal role in the adaptation process. Colocalization of increased RegI with gastric epithelial areas showing increased proliferation also suggests that RegI may be an important mediator of the resolution of mucosal injury that is characteristic of gastric adaptation to aspirin. (Lab Invest 2003, 83:1415-1425.
“…Four hours after exposure to aspirin in rats, we found the number of cells expressing RegI increases specifically in areas close to injury sites, in keeping with the findings of others (Asahara et al, 1996;Kawanami et al, 1997). Once adaptation is established, the number of RegIexpressing cells, and also the level of expression, is increased not only in areas that are injured but also throughout the mucosa in areas that appear macroscopically normal but are likely healing from earlier injury.…”
Section: Discussionsupporting
confidence: 90%
“…It has been clearly demonstrated that RegI is expressed only in endocrine cells, mostly enterochromaffin-like (ECL) cells, in normal and injured rat stomach (Asahara et al, 1996). Four hours after exposure to aspirin in rats, we found the number of cells expressing RegI increases specifically in areas close to injury sites, in keeping with the findings of others (Asahara et al, 1996;Kawanami et al, 1997).…”
Section: Discussionsupporting
confidence: 88%
“…RegI expression has been shown to increase up to 10-fold after a single high dose of indomethacin or after acute water immersion restraint stress (Asahara et al, 1996;Kawanami et al, 1997). In contrast, RegI was not significantly increased in the mucosa after the first aspirin dose in our experiments, although focal increases in expression at sites of injury were observed.…”
Section: Alderman Et Alcontrasting
confidence: 74%
“…RegI was first isolated in 1988 (Terazono et al, 1988) and, although much of the research to date has been concentrated on its role in the pancreas, it has also been shown to be expressed in normal stomach (Watanabe et al, 1990) and to increase after acute gastric mucosal injury (Asahara et al, 1996;Kawanami et al, 1997). In keeping with its mitogenic role in regenerating pancreatic islets, it has been suggested that RegI facilitates normal proliferation in the gastric epithelium and may also augment the proliferation of gastric epithelial cells after injury.…”
SUMMARY:The phenomenon of reduced gastric mucosal injury despite repeated doses of a damaging agent is termed adaptation. Adaptation to nonsteroidal anti-inflammatory drug-induced injury has been clearly demonstrated in both humans and experimental animals; however, the precise mechanisms remain unclear. We hypothesized that mediators of adaptation might be the regenerating protein (RegI) and the trefoil peptides TFF1 and TFF2, because these proteins play pivotal roles in gastric mucosal protection and repair. The gene expression and the protein levels of these proteins were measured and compared in normal, aspirin-injured, and aspirin-adapted rat stomachs. TFF gene and protein expression levels were similar in all three groups, whereas RegI gene expression and protein levels in adapted stomach were increased. A time course analysis of RegI expression during the onset and offset of adaptation showed that mucosal RegI increased during the development of adaptation, was maintained during subsequent aspirin dosing, and returned to baseline levels once dosing had ceased and adaptation was lost-indicative of a causal role in the adaptation process. Colocalization of increased RegI with gastric epithelial areas showing increased proliferation also suggests that RegI may be an important mediator of the resolution of mucosal injury that is characteristic of gastric adaptation to aspirin. (Lab Invest 2003, 83:1415-1425.
“…In addition to the role of Reg I in the pancreas, we have demonstrated that Reg I functions as a growth factor in gastric cells and is involved in gastric mucosal regeneration (Asahara et al, 1996;Fukui et al, 1998;Kazumori et al, 2000). Recently, we generated Reg I-transgenic mice, which showed that Reg I is a key regulatory molecule for the maintenance of the growth axis of the gastric glands (Miyaoka et al, 2004).…”
Reg I (regenerating gene product I) is a growth factor that plays a central role in the generation and regeneration of the gastric mucosal architecture. On the other hand, mouse Reg I mRNA is expressed at the highest levels in the small intestine among the gastrointestinal tissues. In the current study, with the aim to clarify the role of Reg I protein in the small intestine, the temporal and spatial pattern of Reg I expression and the phenotype of Reg I-knockout mice in the tissue were examined. In the wild-type mice, immunohistochemistry localized Reg I protein expression in absorptive cells located in the lower half of the intestinal villi. Reg I expression was undetectable until embryonic day 13 (E13), when the fetal intestine still lacks villous structure; however, it dramatically increased at E17 along with the formation and maturation of the fetal intestinal villi. In the small intestine of the adult Reg I-knockout mice, less densely packed, round-shaped aberrant morphology of the absorptive cells was observed light microscopically, and electron microscopical examination revealed a strikingly loose connection of these cells to the basement membrane. Antiproliferating cell nuclear antigen staining and anti-Ki67 staining demonstrated the marked decrease in the number of proliferating cells in the small intestinal mucosa of the knockout mice. The cell migration speed visualized by one shot labeling of 5-bromodeoxyuridine was significantly slower in the knockout mice. These phenotypes of Reg I-knockout mice emerged, in accordance with the temporal pattern of Reg I expression described above, from E17. Reg I was considered to be a regulator of cell growth that is required to generate and maintain the villous structure of the small intestine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.